ticlopidine has been researched along with Constriction, Pathological in 43 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It is unclear whether cilostazol instead of aspirin in combination with clopidogrel could prevent in-stent thrombosis in patients with a history of gout undergoing vertebral artery origin stenting." | 7.96 | Cilostazol plus clopidogrel in the prevention of in-stent stenosis after vertebral artery origin stenting in gout patients: three case reports. ( Ji, RJ; Lin, YJ; Yuan, HW, 2020) |
| "It is unclear whether cilostazol instead of aspirin in combination with clopidogrel could prevent in-stent thrombosis in patients with a history of gout undergoing vertebral artery origin stenting." | 3.96 | Cilostazol plus clopidogrel in the prevention of in-stent stenosis after vertebral artery origin stenting in gout patients: three case reports. ( Ji, RJ; Lin, YJ; Yuan, HW, 2020) |
| "Anonymous surveys on treatment practices in patients with ICAS were sent to physicians at 3 time points: before publication of the NIH-funded Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) trial (pre-WASID survey, 2004), 1 year after WASID publication (post-WASID survey, 2006) and 1 year after the publication of the NIH-funded Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial (post-SAMMPRIS survey, 2012)." | 3.80 | Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. ( Chimowitz, MI; Cotsonis, G; Derdeyn, CP; Fiorella, D; Lynn, MJ; Stern, BJ; Swanson, S; Turan, TN; Williams, JE; Wooley, RH, 2014) |
| " Aggressive medical management was defined as aspirin plus clopidogrel therapy for a minimum of 3 months, blood pressure control, statin use with a low-density lipoprotein (LDL) goal of <70 mg/dL, smoking cessation, and body mass index <25 kg/m(2)." | 3.79 | Early aggressive medical management for patients with symptomatic intracranial stenosis. ( Ayala, L; Cawley, CM; Dion, JE; Frankel, MR; Hammonds, LP; Kingston, C; Mitchell, B; Nahab, F; Tong, FC, 2013) |
| " Secondary outcomes include target lesion revascularization, major bleeding, ipsilateral major amputation, all-cause mortality, and all adverse events that take place in those six months." | 2.84 | SAFE (Sarpogrelate Anplone in Femoro-popliteal artery intervention Efficacy) study: study protocol for a randomized controlled trial. ( Ahn, S; Cho, MJ; Cho, S; Ha, J; Kim, SY; Lee, J; Min, SI; Min, SK, 2017) |
| "We sought to compare the effects of clopidogrel combined with warfarin with clopidogrel alone in the prevention of restenosis after endovascular treatment (EVT) of the femoropopliteal artery." | 2.78 | A prospective randomized controlled clinical trial on clopidogrel combined with warfarin versus clopidogrel alone in the prevention of restenosis after endovascular treatment of the femoropopliteal artery. ( Feng, Y; Guo, M; Li, H; Liang, G; Luo, X; Zhang, C; Zhang, F, 2013) |
| "Twenty patients with ≥50 % angiographic stenosis of the SFA had blood drawn just proximal to the lesion and from a contralateral site free of disease." | 2.78 | Increased local cytokine production at culprit superficial femoral artery plaques. ( Adams, JE; Ashikaga, T; Bertges, DJ; Dauerman, HL; Donaldson, CW; Elgharib, NZ; Mueller, EL; Prabhu, W; Schneider, DJ, 2013) |
| "Prevention of restenosis in the coronary vasculature has been demonstrated with cilostazol, trapidil, probucol, tranilast, nitric oxide donors, and clopidogrel." | 2.41 | Potential emerging therapeutic strategies to prevent restenosis in the peripheral vasculature. ( Schainfeld, RM, 2002) |
| "This may reflect a reduction in restenosis, although this remains to be proven." | 2.40 | Pharmacologic prevention of acute ischemic complications of coronary angioplasty. ( Cumberland, D; Wheeldon, N, 1997) |
| "Six cases (6." | 1.43 | Complication of Stenting in Intracranial Arterial Stenosis. ( Liu, L; Zhang, F, 2016) |
| "Measuring platelet thrombus formation (PTF) for evaluating antiplatelet effects was assessed." | 1.43 | Measurement of residual platelet thrombogenicity under arterial shear conditions in cerebrovascular disease patients receiving antiplatelet therapy. ( Hosokawa, K; Kawashima, A; Kitagawa, K; Ohnishi, T; Okada, Y; Uchiyama, S; Yamaguchi, K; Yamazaki, M; Yoneyama, T, 2016) |
| "Onyx HD-500 is a liquid embolic used to treat intracranial aneurysms." | 1.39 | Continued concern about parent vessel steno-occlusive progression with Onyx HD-500 and the utility of quantitative magnetic resonance imaging in serial assessment. ( Alaraj, A; Aletich, VA; Amin-Hanjani, S; Carlson, AP; Charbel, FT, 2013) |
| "Intracranial arterial stenosis (IAS) is thought to be responsible for 8% of all ischemic stroke subtypes." | 1.37 | The role of transcranial Doppler embolic monitoring in the management of intracranial arterial stenosis. ( Derksen, C; Khan, K; Saqqur, M; Sebastian, J, 2011) |
| "We report a patient who presented with transient ischemic attack (TIA) associated with stenosis of the accessory MCA ostium." | 1.35 | Transient ischemic attack associated with stenosis of accessory middle cerebral artery: a case report. ( Gao, F; Jiang, WJ, 2009) |
| "We studied 103 patients with MCA stenosis using transcranial Doppler (TCD) and re-evaluated the TCD results at 6 months after the initial investigation and measured platelet aggregability for adenosine diphosphate (ADP) or arachidonic acid (AA)." | 1.35 | Factors related to progression of middle cerebral artery stenosis determined using transcranial Doppler ultrasonograhy. ( Cha, JK; Jeon, HW, 2008) |
| "A 70-year-old male patient with 90% stenosis of the right carotid artery and total occlusion of the left carotid artery underwent right carotid stenting." | 1.34 | Carotid artery in-stent restenosis in a patient with contralateral total occlusion, resolved with drug-eluting stenting. ( Iancu, A; Lazar, A, 2007) |
| "The prognosis of traumatic dissection of the internal carotid artery is worse than for spontaneous dissections." | 1.33 | Endovascular stent-assisted angioplasty in the management of traumatic internal carotid artery dissections. ( Ben-Hur, T; Cohen, JE; Gomori, JM; Rajz, G; Umansky, F, 2005) |
| "No or only a mild restenosis developed in 27 patients." | 1.32 | Clinical and angiographic outcome after interventional treatment of the iliac arteries with a new carbofilm coated stent: preliminary results. ( Butz, B; Feuerbach, S; Lenhart, M; Link, J; Paetzel, C; Pfister, K; Schleicher, T; Stern, U, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (9.30) | 18.2507 |
| 2000's | 10 (23.26) | 29.6817 |
| 2010's | 28 (65.12) | 24.3611 |
| 2020's | 1 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Yuan, HW | 1 |
| Lin, YJ | 1 |
| Ji, RJ | 1 |
| Ahn, S | 1 |
| Lee, J | 1 |
| Min, SK | 1 |
| Ha, J | 1 |
| Min, SI | 1 |
| Kim, SY | 1 |
| Cho, MJ | 1 |
| Cho, S | 1 |
| Li, H | 1 |
| Zhang, F | 2 |
| Liang, G | 1 |
| Luo, X | 1 |
| Zhang, C | 1 |
| Feng, Y | 1 |
| Guo, M | 1 |
| Brown, MM | 1 |
| Turan, TN | 3 |
| Smock, A | 1 |
| Chimowitz, MI | 3 |
| Zhao, R | 1 |
| Feng, XY | 1 |
| Zhang, M | 1 |
| Shen, XL | 1 |
| Su, JJ | 1 |
| Liu, JR | 1 |
| Cotsonis, G | 1 |
| Lynn, MJ | 2 |
| Wooley, RH | 1 |
| Swanson, S | 1 |
| Williams, JE | 1 |
| Stern, BJ | 1 |
| Derdeyn, CP | 2 |
| Fiorella, D | 2 |
| Gory, B | 1 |
| Mazighi, M | 1 |
| Detante, O | 1 |
| Nakiri, GS | 1 |
| Saint-Maurice, JP | 1 |
| Boubagra, K | 1 |
| Houdart, E | 1 |
| George, JC | 1 |
| Rosen, ES | 1 |
| Nachtigall, J | 1 |
| VanHise, A | 1 |
| Kovach, R | 1 |
| Ma, N | 3 |
| Xu, Z | 1 |
| Mo, D | 2 |
| Gao, F | 3 |
| Gao, K | 1 |
| Sun, X | 2 |
| Xu, X | 1 |
| Liu, L | 3 |
| Song, L | 1 |
| Wang, T | 1 |
| Zhao, X | 2 |
| Wang, Y | 4 |
| Miao, Z | 3 |
| Wong, KS | 3 |
| Leng, X | 1 |
| Pu, Y | 1 |
| Jing, J | 1 |
| Zou, X | 1 |
| Pan, Y | 1 |
| Wang, A | 1 |
| Meng, X | 1 |
| Wang, C | 1 |
| Soo, Y | 1 |
| Johnston, SC | 1 |
| Lutsep, HL | 1 |
| Cotsonis, GA | 1 |
| Janis, LS | 1 |
| Lane, BF | 1 |
| Montgomery, J | 1 |
| Wilson, LK | 1 |
| Pearce, LA | 1 |
| Arauz, A | 1 |
| Anderson, DC | 1 |
| Tapia, J | 1 |
| Bazan, C | 1 |
| Benavente, OR | 1 |
| Field, TS | 1 |
| Yamazaki, M | 1 |
| Ohnishi, T | 1 |
| Hosokawa, K | 1 |
| Yamaguchi, K | 1 |
| Yoneyama, T | 1 |
| Kawashima, A | 1 |
| Okada, Y | 1 |
| Kitagawa, K | 1 |
| Uchiyama, S | 1 |
| Zhao, Z | 1 |
| Li, X | 1 |
| Sun, S | 1 |
| Mei, S | 1 |
| Zhao, M | 1 |
| Peng, S | 1 |
| Tong, X | 1 |
| Lo, WT | 1 |
| Wang, B | 1 |
| Thott, O | 1 |
| Granath, F | 1 |
| Malmstedt, J | 1 |
| Wahlgren, CM | 1 |
| Jiang, WJ | 1 |
| Sebastian, J | 1 |
| Derksen, C | 1 |
| Khan, K | 1 |
| Saqqur, M | 1 |
| Naik, A | 1 |
| Mian, T | 1 |
| Abraham, A | 1 |
| Rajput, V | 1 |
| Stewart, K | 1 |
| Walters, M | 1 |
| Dawson, J | 1 |
| Nahab, F | 1 |
| Kingston, C | 1 |
| Frankel, MR | 1 |
| Dion, JE | 1 |
| Cawley, CM | 1 |
| Mitchell, B | 1 |
| Hammonds, LP | 1 |
| Ayala, L | 1 |
| Tong, FC | 1 |
| Kwon, SU | 1 |
| Hong, KS | 1 |
| Kang, DW | 1 |
| Park, JM | 1 |
| Lee, JH | 1 |
| Cho, YJ | 1 |
| Yu, KH | 1 |
| Koo, JS | 1 |
| Lee, SH | 1 |
| Lee, KB | 1 |
| Kim, DE | 1 |
| Jeong, SW | 1 |
| Bae, HJ | 1 |
| Lee, BC | 1 |
| Han, MK | 1 |
| Rha, JH | 1 |
| Kim, HY | 1 |
| Mok, VC | 1 |
| Lee, YS | 1 |
| Kim, GM | 1 |
| Suwanwela, NC | 1 |
| Yun, SC | 1 |
| Nah, HW | 1 |
| Kim, JS | 1 |
| Rosenberg, K | 1 |
| Linnemann, B | 1 |
| Thalhammer, A | 1 |
| Wolf, Z | 1 |
| Tirneci, V | 1 |
| Vogl, TJ | 1 |
| Edelgard Lindhoff-Last, A | 1 |
| Wang, X | 1 |
| Lin, WH | 1 |
| Zhao, YD | 1 |
| Chen, XY | 1 |
| Leung, TW | 1 |
| Chen, C | 1 |
| Fu, J | 1 |
| Markus, H | 1 |
| Hao, Q | 1 |
| Meltzer, AJ | 1 |
| Da Silva, P | 1 |
| Schneider, DB | 1 |
| Shrikhande, GV | 1 |
| Carlson, AP | 1 |
| Alaraj, A | 1 |
| Amin-Hanjani, S | 1 |
| Charbel, FT | 1 |
| Aletich, VA | 1 |
| Donaldson, CW | 1 |
| Schneider, DJ | 1 |
| Bertges, DJ | 1 |
| Adams, JE | 1 |
| Elgharib, NZ | 1 |
| Mueller, EL | 1 |
| Prabhu, W | 1 |
| Ashikaga, T | 1 |
| Dauerman, HL | 1 |
| Schainfeld, RM | 1 |
| Butz, B | 1 |
| Paetzel, C | 1 |
| Stern, U | 1 |
| Schleicher, T | 1 |
| Pfister, K | 1 |
| Link, J | 1 |
| Feuerbach, S | 1 |
| Lenhart, M | 1 |
| Ferrara, F | 1 |
| Meli, F | 1 |
| Raimondi, F | 1 |
| Milio, G | 1 |
| Amato, C | 1 |
| Cospite, V | 1 |
| Cospite, M | 1 |
| Novo, S | 1 |
| Cohen, JE | 1 |
| Ben-Hur, T | 1 |
| Rajz, G | 1 |
| Umansky, F | 1 |
| Gomori, JM | 1 |
| Biondi, A | 1 |
| Katz, JM | 1 |
| Vallabh, J | 1 |
| Segal, AZ | 1 |
| Gobin, YP | 1 |
| Iancu, A | 1 |
| Lazar, A | 1 |
| Jeon, HW | 1 |
| Cha, JK | 1 |
| McBane, RD | 1 |
| Leadley, RJ | 1 |
| Baxi, SM | 1 |
| Karnicki, K | 1 |
| Wysokinski, W | 1 |
| Müller-Schunk, S | 1 |
| Linn, J | 1 |
| Peters, N | 1 |
| Spannagl, M | 1 |
| Deisenberg, M | 1 |
| Brückmann, H | 1 |
| Mayer, TE | 1 |
| Yao, SK | 1 |
| McNatt, J | 1 |
| Cui, K | 1 |
| Anderson, HV | 1 |
| Maffrand, JP | 1 |
| Buja, LM | 1 |
| Willerson, JT | 1 |
| Neumann, FJ | 1 |
| Gawaz, M | 1 |
| Dickfeld, T | 1 |
| Wehinger, A | 1 |
| Walter, H | 1 |
| Blasini, R | 1 |
| Schomig, A | 1 |
| Wheeldon, N | 1 |
| Cumberland, D | 1 |
| Herbert, JM | 1 |
| Dol, F | 1 |
| Bernat, A | 1 |
| Falotico, R | 1 |
| Lalé, A | 1 |
| Savi, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study : a Randomized Controlled Trial[NCT02959606] | Phase 4 | 272 participants (Anticipated) | Interventional | 2016-12-31 | Recruiting | ||
| Randomized,Double-blind Trial Comparing the Effects of a 3-month Clopidogrel Regimen,Combined With ASA During the First 21days,Versus ASA Alone for the Acute Treatment of TIA or Minor Stroke[NCT00979589] | Phase 3 | 5,100 participants (Actual) | Interventional | 2009-12-31 | Completed | ||
| Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis[NCT00576693] | Phase 3 | 451 participants (Actual) | Interventional | 2008-10-31 | Completed | ||
| Secondary Prevention of Small Subcortical Strokes (SPS3) Trial[NCT00059306] | Phase 3 | 3,020 participants (Actual) | Interventional | 2003-02-28 | Completed | ||
| Trial for Efficacy and Safety of Cilostazol on the Progression of Symptomatic Intracranial Stenosis Comparing Clopidogrel[NCT00130039] | Phase 4 | 457 participants (Actual) | Interventional | 2005-08-31 | Completed | ||
| Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial): Does Clopidogrel Prevent Saphenous Vein Graft Disease After Coronary Bypass?[NCT00228423] | Phase 2 | 113 participants (Actual) | Interventional | 2006-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Any stroke (ischemic, parenchymal brain hemorrhage, subarachnoid or intraventricular hemorrhage) or death within 30 days after enrollment OR any stroke (ischemic, parenchymal brain hemorrhage, subarachnoid or intraventricular hemorrhage) or death within 30 days of any revascularization procedure of the qualifying symptomatic intracranial artery done during follow-up, OR an ischemic stroke in the territory of the symptomatic intracranial artery from day 31 after study entry to completion of follow-up. (NCT00576693)
Timeframe: Mean length of follow-up was 2.4 years
| Intervention | participants (Number) |
|---|---|
| Intensive Medical Management Plus Stenting | 52 |
| Intensive Medical Management Alone | 34 |
number of patients with new ischemic lesions on FLAIR (Fluid attenuation inversion recovery) images of follow-up MRI, which were determined by slice to slice comparison with baseline MRI. (NCT00130039)
Timeframe: 7 months after treatment
| Intervention | pariticipants (Number) |
|---|---|
| Cilostazol | 34 |
| Clopidogrel | 23 |
including nonfatal stroke, nonfatal myocardial infarction and vascular death. (NCT00130039)
Timeframe: upto 7 months after randomization
| Intervention | participants (Number) |
|---|---|
| Cilostazol | 15 |
| Clopidogrel | 10 |
"Blind reviewers classified the presence and severity of stenosis on middle cerebral arteries and basilar artery on magnetic resonance angiogram (MRA) into 5 grades; normal, mild, moderate, severe and occlusion. Progression was defined as worsening of stenosis by 1 or more grades on final MRA as compared with the baseline MRA.~The progression of symptomatic stenosis is defined as 1 or more grade worsening of the stenosis on the symptomatic artery on MRA." (NCT00130039)
Timeframe: 7 months after treatment
| Intervention | participants (Number) |
|---|---|
| Cilostazol | 20 |
| Clopidogrel | 32 |
including nonfatal ischemic stroke, nonfatal hemorrhagic stroke and fatal stroke (NCT00130039)
Timeframe: upto 7 months after randomization
| Intervention | participants (Number) |
|---|---|
| Cilostazol | 11 |
| Clopidogrel | 7 |
ischemic stroke event which occured in the vascular territory of initial symptomatic stenosis (NCT00130039)
Timeframe: upto 7 months after randomization
| Intervention | participants (Number) |
|---|---|
| Cilostazol | 9 |
| Clopidogrel | 5 |
life-threatening or fatal bleeding was defined as any fatal bleeding event, a drop in hemoglobin of ≥ 50g/L, or significant hypotension with need for inotropic agents, symptomatic intracranial hemorrhage, or transfusion of ≥ 4 units of red-blood cells or equivalent amount of whole blood. Major bleeding was defined as significantly disabling bleedings, intraocular bleeding leading to significant visual loss, or bleeding requiring transfusion of ≤ 3 units of red-blood cells or equivalent amount of whole blood (NCT00130039)
Timeframe: upto 7 months after randomization
| Intervention | events (Number) |
|---|---|
| Cilostazol | 2 |
| Clopidogrel | 6 |
(NCT00228423)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| 75mg Clopidogrel | 4 |
| Placebo | 5 |
(NCT00228423)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| 75mg Clopidogrel | 1 |
| Placebo | 0 |
Postoperative angiogram 12 months post-CABG (NCT00228423)
Timeframe: One year following surgery
| Intervention | percentage (Number) |
|---|---|
| 75mg Clopidogrel | 94.3 |
| Placebo | 93.2 |
IVUS imaging 12 months post-CABG, and the average intimal area in the proximal 40 mm of one vein graft per patient will be assessed (NCT00228423)
Timeframe: One year following surgery
| Intervention | mm (Mean) |
|---|---|
| 75mg Clopidogrel | 4.1 |
| Placebo | 4.5 |
4 reviews available for ticlopidine and Constriction, Pathological
| Article | Year |
|---|---|
Aggressive medical therapy alone is not adequate in certain patients with severe symptomatic carotid stenosis.
Topics: Aspirin; Atorvastatin; Carotid Artery Diseases; Clopidogrel; Constriction, Pathologic; Endovascular | 2013 |
The challenge of stroke prevention with intracranial arterial stenosis.
Topics: Aspirin; Carotid Artery, Common; Carotid Stenosis; Clopidogrel; Constriction, Pathologic; Drug Thera | 2013 |
Potential emerging therapeutic strategies to prevent restenosis in the peripheral vasculature.
Topics: Animals; Blood Vessels; Brachytherapy; Cilostazol; Clopidogrel; Constriction, Pathologic; Drug Deliv | 2002 |
Pharmacologic prevention of acute ischemic complications of coronary angioplasty.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Constriction, Pathologic | 1997 |
11 trials available for ticlopidine and Constriction, Pathological
| Article | Year |
|---|---|
SAFE (Sarpogrelate Anplone in Femoro-popliteal artery intervention Efficacy) study: study protocol for a randomized controlled trial.
Topics: Amputation, Surgical; Aspirin; Clinical Protocols; Clopidogrel; Computed Tomography Angiography; Con | 2017 |
A prospective randomized controlled clinical trial on clopidogrel combined with warfarin versus clopidogrel alone in the prevention of restenosis after endovascular treatment of the femoropopliteal artery.
Topics: Aged; Anticoagulants; Clopidogrel; Constriction, Pathologic; Drug Therapy, Combination; Endovascular | 2013 |
Aggressive medical therapy alone is not adequate in certain patients with severe symptomatic carotid stenosis.
Topics: Aspirin; Atorvastatin; Carotid Artery Diseases; Clopidogrel; Constriction, Pathologic; Endovascular | 2013 |
Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE.
Topics: Aged; Aspirin; Clopidogrel; Constriction, Pathologic; Double-Blind Method; Drug Therapy, Combination | 2015 |
Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?
Topics: Angioplasty; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Clopidogrel; Constriction, Patholo | 2015 |
Morphological classification of penetrating artery pontine infarcts and association with risk factors and prognosis: The SPS3 trial.
Topics: Antihypertensive Agents; Aspirin; Cerebral Infarction; Clopidogrel; Constriction, Pathologic; Double | 2016 |
Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis.
Topics: Aged; Asian People; Aspirin; Carboxylic Ester Hydrolases; Clopidogrel; Constriction, Pathologic; Cyt | 2016 |
Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis.
Topics: Aged; Aged, 80 and over; Cilostazol; Clopidogrel; Constriction, Pathologic; Disease Progression; Dou | 2011 |
The effectiveness of dual antiplatelet treatment in acute ischemic stroke patients with intracranial arterial stenosis: a subgroup analysis of CLAIR study.
Topics: Aspirin; Cerebrovascular Disorders; Clopidogrel; Constriction, Pathologic; Drug Therapy, Combination | 2013 |
Increased local cytokine production at culprit superficial femoral artery plaques.
Topics: Aspirin; CD40 Ligand; Clopidogrel; Constriction, Pathologic; Female; Femoral Artery; Humans; Hydroxy | 2013 |
Antiplatelet effect of ticlopidine after coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Constriction, Pathologic; Cor | 1997 |
29 other studies available for ticlopidine and Constriction, Pathological
| Article | Year |
|---|---|
Cilostazol plus clopidogrel in the prevention of in-stent stenosis after vertebral artery origin stenting in gout patients: three case reports.
Topics: Aged; Brain Ischemia; Cilostazol; Clopidogrel; Constriction, Pathologic; Drug Therapy, Combination; | 2020 |
Progressive hemorrhagic transformation following dual antiplatelet therapy.
Topics: Angiography, Digital Subtraction; Aspirin; Brain; Cerebral Angiography; Cerebral Hemorrhage; Clopido | 2014 |
Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.
Topics: Angioplasty; Aspirin; Cerebral Arteries; Clopidogrel; Constriction, Pathologic; Drug Therapy, Combin | 2014 |
Interest of platelet inhibition monitoring in intracranial arterial stenosis before stenting.
Topics: Aged; Cell Adhesion Molecules; Clopidogrel; Constriction, Pathologic; Drug Monitoring; Drug Resistan | 2014 |
SUPERA interwoven nitinol Stent Outcomes in Above-Knee IntErventions (SAKE) study.
Topics: Aged; Aged, 80 and over; Alloys; Ankle Brachial Index; Aspirin; Clopidogrel; Constriction, Pathologi | 2014 |
Safety of low-dose aspirin in endovascular treatment for intracranial atherosclerotic stenosis.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Constriction, Pathologic; Female; Humans; Male | 2014 |
Complication of Stenting in Intracranial Arterial Stenosis.
Topics: Age Factors; Aged; Angioplasty; Aspirin; China; Clopidogrel; Computed Tomography Angiography; Constr | 2016 |
Measurement of residual platelet thrombogenicity under arterial shear conditions in cerebrovascular disease patients receiving antiplatelet therapy.
Topics: Adult; Aged; Arteries; Aspirin; Blood Coagulation Tests; Blood Platelets; Carotid Arteries; Cell Adh | 2016 |
Risk Factors of Subacute Thrombosis After Intracranial Stenting for Symptomatic Intracranial Arterial Stenosis.
Topics: Adult; Aged; Aspirin; Clopidogrel; Constriction, Pathologic; Female; Humans; Ischemic Attack, Transi | 2017 |
Editor's Choice - Dual Antiplatelet Therapy Improves Outcome in Diabetic Patients Undergoing Endovascular Femoropopliteal Stenting for Critical Limb Ischaemia.
Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Aspirin; Clopidogrel; Constriction, Pathologic | 2017 |
Transient ischemic attack associated with stenosis of accessory middle cerebral artery: a case report.
Topics: Aphasia; Aspirin; Cerebral Angiography; Clopidogrel; Constriction, Pathologic; Humans; Hypertension; | 2009 |
The role of transcranial Doppler embolic monitoring in the management of intracranial arterial stenosis.
Topics: Angiography, Digital Subtraction; Aspirin; Atorvastatin; Blood Flow Velocity; Cerebral Angiography; | 2011 |
Iliac vein compression syndrome: an underdiagnosed cause of lower extremity deep venous thrombosis.
Topics: Anticoagulants; Clopidogrel; Constriction, Pathologic; Heparin; Humans; Iliac Vein; Lower Extremity; | 2010 |
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90).
Topics: Aspirin; Clopidogrel; Constriction, Pathologic; Delayed-Action Preparations; Dipyridamole; Drugs, Ge | 2011 |
Early aggressive medical management for patients with symptomatic intracranial stenosis.
Topics: Aged; Antihypertensive Agents; Aspirin; Biomarkers; Blood Pressure; Body Mass Index; Cerebral Angiog | 2013 |
Medical management trumps stenting for intracranial arterial stenosis.
Topics: Angioplasty; Aspirin; Cerebral Arteries; Clopidogrel; Combined Modality Therapy; Constriction, Patho | 2011 |
Late peripheral stent thrombosis due to stent fracture, vigorous exercise and hyporesponsiveness to clopidogrel.
Topics: Aged; Angioplasty; Arterial Occlusive Diseases; Bicycling; Clopidogrel; Constriction, Pathologic; Dr | 2012 |
Clinical significance of the clopidogrel-proton pump inhibitor interaction after peripheral endovascular intervention for claudication.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Chi-Square Distribution; Clopidogrel; Comorbidity; Co | 2012 |
Continued concern about parent vessel steno-occlusive progression with Onyx HD-500 and the utility of quantitative magnetic resonance imaging in serial assessment.
Topics: Angioplasty; Aspirin; Carotid Artery Diseases; Carotid Stenosis; Clopidogrel; Constriction, Patholog | 2013 |
Clinical and angiographic outcome after interventional treatment of the iliac arteries with a new carbofilm coated stent: preliminary results.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiography; Anticoagulants; Arterial Occlusive Disea | 2004 |
Subclavian stenosis/occlusion in patients with subclavian steal and previous bypass of internal mammary interventricular anterior artery: medical or surgical treatment?
Topics: Aged; Angioplasty; Aspirin; Constriction, Pathologic; Female; Humans; Internal Mammary-Coronary Arte | 2004 |
Endovascular stent-assisted angioplasty in the management of traumatic internal carotid artery dissections.
Topics: Adult; Angiography; Angioplasty; Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis I | 2005 |
Progressive symptomatic carotid dissection treated with multiple stents.
Topics: Angiography; Angioplasty; Anticoagulants; Aspirin; Blood Vessel Prosthesis Implantation; Carotid Art | 2005 |
Carotid artery in-stent restenosis in a patient with contralateral total occlusion, resolved with drug-eluting stenting.
Topics: Aged; Angioplasty, Balloon; Carotid Arteries; Carotid Artery Thrombosis; Carotid Stenosis; Catheteri | 2007 |
Factors related to progression of middle cerebral artery stenosis determined using transcranial Doppler ultrasonograhy.
Topics: Adenosine Diphosphate; Aged; Aspirin; Cerebral Angiography; Clopidogrel; Constriction, Pathologic; D | 2008 |
Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigs.
Topics: Administration, Oral; Angioplasty; Animals; Antithrombin III; Aspirin; Clopidogrel; Constriction, Pa | 2008 |
Monitoring of clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stenting.
Topics: Adult; Aged; Basilar Artery; Carotid Artery, Internal; Clopidogrel; Constriction, Pathologic; Drug M | 2008 |
Combined ADP and thromboxane A2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in nonhuman primates.
Topics: Adenosine Diphosphate; Animals; Clopidogrel; Constriction, Pathologic; Coronary Vessels; Dogs; Endot | 1993 |
The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit.
Topics: Animals; Aspirin; Clopidogrel; Constriction, Pathologic; Drug Synergism; Femoral Artery; Fibrinolyti | 1998 |